Dogwood Therapeutics (DWTX) Exchange Rate Effect (2025 - 2026)
Dogwood Therapeutics (DWTX) posted Exchange Rate Effect of -$6742.0 for Q2 2026, down 546.4% on a QoQ basis from -$1043.0 in Q1 2026, and down 167.04% year-over-year from $10056.0 in Q2 2025.
Powered by 
Analysis
Dogwood Therapeutics (DWTX) Exchange Rate Effect (2025 - 2026) Analysis & Trends
Dogwood Therapeutics has reported Exchange Rate Effect for 2 years, with the latest figure at -$6742.0 in Q2 2026.
- On a quarterly basis, Exchange Rate Effect fell 167.04% year-over-year to -$6742.0 in Q2 2026; TTM through Jun 2026 was -$8432.0, a N/A change from a year earlier, with the FY2025 full-year figure at $10640.0, up 107.36% from the prior year.
- Exchange Rate Effect was -$6742.0 for Q2 2026 at Dogwood Therapeutics, down from -$1043.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $10056.0 in Q2 2025, with the low at -$6742.0 in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 315,000.00 |
| 10 | Dogwood Therapeutics | 65.53 Mn | 65.53 Mn | - | -6,742.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6,742.00 |
| Mar 31, 2026 | -1,043.00 |
| Dec 31, 2025 | 2,660.00 |
| Sep 30, 2025 | -3,307.00 |
| Jun 30, 2025 | 10,056.00 |
| Mar 31, 2025 | 1,231.00 |